Pediatric Pulmonary Vascular Disease

Current State of RV Multimodality Imaging in Pediatric Pulmonary Hypertension: Current Evidence, Knowledge Gaps, and Future Research Directions

Kimberley G. Miles, Dan M. Dorobantu, Johannes Menno Douwes, Benjamin S. Frank, Pei-Ni Jone, Vivek Muthurangu, D. Dunbar Ivy, Hythem Nawaytou, Mark K. FriedbergCincinnati Children’s Hospital and University of Cincinnati College of Medicine. Bristol Royal Hospital for Children and Heart Institute. Beatrix Children’s Hospital, University Medical Center Groningen and University of Groningen. University of Colorado Denver Anschutz […]

Current State of RV Multimodality Imaging in Pediatric Pulmonary Hypertension: Current Evidence, Knowledge Gaps, and Future Research Directions Read More »

Peri and Neonatal Risk Factors and Structural Lung Abnormalities Predict Hypoxic Challenge Test Failure in Infants With Severe Bronchopulmonary Dysplasia

Kishan D. Tsang, Daan Caudri, Citta Zaat, Gerdien A. Tramper‐Stranders, Isme M. de Kleer, Pierluigi Ciet, Irwin K. M. Reiss, Liesbeth Duijts, Mariëlle W. PijnenburgErasmus Medical Centre, Sophia Children’s Hospital and University Medical Center. Franciscus Gasthuis & Vlietland. University of Cagliari. University Children’s Hospital, University Medical Center Hamburg Eppendorf. Netherlands, Italy, Germany Pediatric PulmonologyPediatr Pulmonol

Peri and Neonatal Risk Factors and Structural Lung Abnormalities Predict Hypoxic Challenge Test Failure in Infants With Severe Bronchopulmonary Dysplasia Read More »

Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia

Henry P. Foote, Minghui Sun, Benjamin Alan Goldstein, Kevin D. Hill, Rachel G. Greenberg, Samuel J. Gentle, Kanecia O. Zimmerman, Rishikesan Kameleswaran, Veeral N. Tolia, Matthew M. Laughon, Wesley Jackson, Christoph P. HornikDuke University Medical Center and Duke University. Yale University School of Medicine. Baylor University Medical Center. University of North Carolina. United States Journal

Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia Read More »

Results of a pulmonary hypertension screening program for premature infants with bronchopulmonary dysplasia

Ramya Ramachandra, Alisa Arunamata, Amanda Moy, Michael C. Tracy, Yinyao Ji, Derek Boothroyd, Rachel K. HopperStanford University School of Medicine and Lucile Packard Children’s Hospital.United States Journal of PerinatologyJ Perinatol 2026; DOI: 10.1038/s41372-026-02580-6 AbstractObjective: Premature infants with bronchopulmonary dysplasia (BPD) are at risk for pulmonary hypertension (PH). We sought to evaluate outcomes of a PH screening protocol.Study

Results of a pulmonary hypertension screening program for premature infants with bronchopulmonary dysplasia Read More »

Jinlong Liu, Xiafeng Yu, Jiwen Xiong, Yi Yan, Yanjun Sun, Yumin Zhong, Hao ZhangShanghai Children’s Medical Center and Shanghai Jiao Tong University School of Medicine.China Frontiers in Bioengineering and BiotechnologyFront Bioeng Biotechnol 2026; 13: DOI: 10.3389/fbioe.2025.1697468 AbstractObjectives: Reverse Potts shunt is a promising yet high-risk therapy for pediatric pulmonary arterial hypertension. Postoperative hemodynamics is critically influenced by

Read More »

A Large Animal Model of Heritable Pulmonary Arterial Hypertension Using Gene-edited BMPR2 Sheep

Sanjeev A. Datar, Nicholas Werry, Austin R. Brown, Devon S. Fitzpatrick, Oluwafemi Falade, Josephine F. Trott, Rachel Hutchings, Elena K. Amin, Jessica M. Morgan, Hythem Nawaytou, Gail H. Deutsch, Eric G. Johnson, Omar A. Gonzales Viera, Thomas F. Bishop, Tara Urbano, Bret R. McNabb, Eric D. Austin, Jeffery R. Fineman, and Alison L. Van EenennaamUniversity

A Large Animal Model of Heritable Pulmonary Arterial Hypertension Using Gene-edited BMPR2 Sheep Read More »

The First 1000 Days: Maternal Nutrient Intake-A Window of Opportunity for Pulmonary Hypertension-A Narrative Review

Alina-Costina Luca, Solange Tamara Rosu, Cosmin Diaconescu, Dana Elena Mîndru, Cristina Gavrilovici, Adriana Vizireanu, Viorel Tarcă, Eduard Vasile Rosu, Elena TarcăGrigore T. Popa University of Medicine and Pharmacy. Apollonia University. Romania NutrientsNutrients 2026; 18: DOI: 10.3390/nu18030424 AbstractThe first 1000 days of life, starting from conception to a child’s second birthday, constitute a pivotal period for fetal

The First 1000 Days: Maternal Nutrient Intake-A Window of Opportunity for Pulmonary Hypertension-A Narrative Review Read More »

Cardiac Magnetic Resonance Findings and Their Association with Clinical Outcomes in Pediatric Pulmonary Arterial Hypertension: An Exploratory Study

Meryem Beyazal, Merter Keceli, Oguzhan Dogan, Ibrahim EceChildren Hospital and Ankara Bilkent City Hospital.Turkey Journal of Clinical MedicineJ Clin Med 2026; 15: DOI: 10.3390/jcm15031107 AbstractBackground: Cardiac magnetic resonance [CMR] is a non-invasive tool to assess ventricular function in pediatric pulmonary arterial hypertension [PAH]. However, CMR parameters in children remain underexplored. Methods: Thirty-six children with PAH were prospectively

Cardiac Magnetic Resonance Findings and Their Association with Clinical Outcomes in Pediatric Pulmonary Arterial Hypertension: An Exploratory Study Read More »

Development of a Robust, Rapid and Reliable Tandem Mass Spectrometry Method for the Measurement of Sildenafil, Bosentan and their Major Metabolites

Mohammad Ahmad Bik, Duygu Eryavuz, Onmaz, Karem Mazin Kamil Gharab, Fadime Karaman, Sedat Abusoglu, Abdullah Sivrikaya, Ali UnluSelcuk University. Mustansiriyah University.Turkey and Iraq Indian Journal of Clinical BiochemistryIndian J Clin Biochem 2026; 41: 113-119DOI: 10.1007/s12291-024-01215-x AbstractPulmonary arterial hypertension (PAH) is a lethal, progressive disease with a complex pathogenesis. Bosentan, a dual endothelin receptor antagonist, and sildenafil,

Development of a Robust, Rapid and Reliable Tandem Mass Spectrometry Method for the Measurement of Sildenafil, Bosentan and their Major Metabolites Read More »

Beyond the Echocardiogram: Cardiac Catheterization in Infants With Bronchopulmonary Dysplasia Associated Pulmonary Hypertension

Samuel J. Gentle, Audrey HebertYale School of Medicine. Centre Hospitalier Universitaire de Quebec.United States and Canada Journal of PediatricsJ Pediatr 2026; DOI: 10.1016/j.jpeds.2026.115026 AbstractAbstract Not Available CategoryClass III. Pulmonary Hypertension Associated with Lung DiseaseDiagnostic Testing for Pulmonary Vascular Disease. Non-invasive TestingDiagnostic Testing for Pulmonary Vascular Disease. Invasive Testing Age Focus: Pediatric Pulmonary Vascular Disease Fresh or

Beyond the Echocardiogram: Cardiac Catheterization in Infants With Bronchopulmonary Dysplasia Associated Pulmonary Hypertension Read More »

Scroll to Top